Metacrine Financials
MTCRDelisted Stock | USD 0.49 0.00 0.00% |
Metacrine |
Metacrine Stock Summary
Metacrine competes with Protara Therapeutics, CytomX Therapeutics, Assembly Biosciences, Instil Bio, and Nuvation Bio. Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California. Metacrine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US59101E1038 |
Business Address | 3985 Sorrento Valley |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | www.metacrine.com |
Phone | 858 369 7800 |
Currency | USD - US Dollar |
Metacrine Key Financial Ratios
Metacrine Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Metacrine's current stock value. Our valuation model uses many indicators to compare Metacrine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Metacrine competition to find correlations between indicators driving Metacrine's intrinsic value. More Info.Metacrine is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Metacrine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Metacrine Market Pulse
Quote | 0.49 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 0.49 |
Low | 0.43 |
High | 0.52 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Metacrine is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Metacrine has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Metacrine's financials are consistent with your investment objective using the following steps:- Review Metacrine's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Metacrine's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Metacrine's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Metacrine's stock is overvalued or undervalued.
Metacrine December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Metacrine help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Metacrine. We use our internally-developed statistical techniques to arrive at the intrinsic value of Metacrine based on widely used predictive technical indicators. In general, we focus on analyzing Metacrine Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Metacrine's daily price indicators and compare them against related drivers.
Downside Deviation | 3.76 | |||
Information Ratio | 0.0739 | |||
Maximum Drawdown | 21.01 | |||
Value At Risk | (4.65) | |||
Potential Upside | 9.09 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Metacrine Stock
If you are still planning to invest in Metacrine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Metacrine's history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |